Antibiotic resistance-the need for global solutions (Q34386251)

1 August 2017

Antibiotic resistance-the need for global solutions (English)

1 reference

1 August 2017

antibiotic resistance

1 reference

10

Herman Goossens

0 references

Fatima Mir

Fatima Mir

19

0 references

Göran Tomson

Göran Tomson

14

0 references

Gerard D. Wright

Gerard D Wright

24

0 references

Zulfiqar Bhutta

21

Zulfiqar A Bhutta

1 reference

1 August 2017

20

Sam Kariuki

1 reference

1 August 2017

13

Maryam Bigdeli

1 reference

Heiman Frank Louis Wertheim

1 August 2017

5

Heiman F L Wertheim

1 reference

1 August 2017

1

Ramanan Laxminarayan

1 reference

1 August 2017

4

Anita K M Zaidi

1 reference

1 August 2017

Adriano Duse

2

1 reference

1 August 2017

Chand Wattal

3

1 reference

1 August 2017

Nithima Sumpradit

6

1 reference

1 August 2017

Erika Vlieghe

7

1 reference

1 August 2017

Gabriel Levy Hara

8

1 reference

1 August 2017

Ian M Gould

9

1 reference

1 August 2017

Christina Greko

11

1 reference

1 August 2017

Anthony D So

12

1 reference

1 August 2017

Will Woodhouse

15

1 reference

1 August 2017

Eva Ombaka

16

1 reference

1 August 2017

Arturo Quizhpe Peralta

17

1 reference

1 August 2017

Farah Naz Qamar

18

1 reference

1 August 2017

Anthony Coates

22

1 reference

1 August 2017

Richard Bergstrom

23

1 reference

1 August 2017

Eric D Brown

25

1 reference

1 August 2017

Otto Cars

26

1 reference

1 August 2017

17 November 2013

1 reference

Lancet Infectious Diseases

1 August 2017

1 reference

1 August 2017

13

1 reference

1 August 2017

1057-1098

1 reference

1 August 2017

12

1 reference

Challenges of drug resistance in the developing world

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Origins and evolution of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Studies of venereal disease. I. Probenecid-procaine penicillin G combination and tetracycline hydrochloride in the treatment of "penicillin-resistant" gonorrhea in men

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

History of U.S. military contributions to the study of sexually transmitted diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Global spread of Carbapenemase-producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Transferable mechanisms of quinolone resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Hospital-acquired neonatal infections in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Profile of neonatal septicaemia at a district-level sick newborn care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Pan-resistant Acinetobacter Infection in Neonates in Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Prevalent genotypes of meticillin-resistant Staphylococcus aureus: report from Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Health and economic impacts of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The emerging problem of linezolid-resistant Staphylococcus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of Mexico. Detection of linezolid resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The true cost of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Variability in outpatient antimicrobial consumption in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Regional variations in community consumption of antibiotics in Hungary, 1996-2003

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Non-prescription antimicrobial use worldwide: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Association between health insurance and antibiotics prescribing in four counties in rural China.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Nonjudicious dispensing of antibiotics by drug stores in Pratumthani, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial resistance: priorities for action

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Bacterial diversity in faeces from polar bear (Ursus maritimus) in Arctic Svalbard

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotic prescribing in DR Congo: a knowledge, attitude and practice survey among medical doctors and students

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

1 reference

7 January 2021

Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Implementation of the Campaign to Prevent Antimicrobial Resistance in Healthcare Settings: 12 Steps to Prevent Antimicrobial Resistance Among Hospitalized Adults--experiences from 3 institutions.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Temporal effects of antibiotic use and Clostridium difficile infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Do guidelines influence the implementation of health programs?--Uganda's experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Providing impetus, tools, and guidance to strengthen national capacity for antimicrobial stewardship in Viet Nam.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Constraining the use of antibiotics: applying Scanlon's contractualism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Comparison of methods of measuring pharmacy sales of antibiotics without prescriptions in Pratumthani, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Improving antibiotic use in low-income countries: an overview of evidence on determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Behavioral economics: merging psychology and economics for lifestyle interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotic overuse: the influence of social norms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial stewardship programs in health care systems

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Socioeconomic determinants of outpatient antibiotic use in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotics in the community: a typology of user behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The role of poverty in antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Human use of antimicrobial agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Trends in antibiotic utilization in eight Latin American countries, 1997-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Telemedicine can help to ensure that patients receive timely medical care

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Application of basic pharmacology and dispensing practice of antibiotics in accredited drug-dispensing outlets in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

How to educate prescribers in antimicrobial stewardship practices

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Communicating trends in resistance using a drug resistance index

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Advances in microfluidic PCR for point-of-care infectious disease diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Rapid detection of antibiotic-resistant organism carriage for infection prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Clinical and economic evaluation of the impact of rapid microbiological diagnostic testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Emergence and spread of antibiotic resistance following exposure to antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Detection and fate of antibiotic resistant bacteria in wastewater treatment plants: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Metagenomic insights into chlorination effects on microbial antibiotic resistance in drinking water

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Interventions to improve antibiotic prescribing practices for hospital inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Bacterial death comes full circle: targeting plasmid replication in drug-resistant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Phage renaissance: new hope against antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotic stewardship implementation in the EU: the way forward.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Health laboratories in the Tanga region of Tanzania: the quality of diagnostic services for malaria and other communicable diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Development of chip-compatible sample preparation for diagnosis of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Diagnostics as essential tools for containing antibacterial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A guide for diagnostic evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Two quality control exercises involving nucleic acid amplification methods for detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and carried out 2 years apart (in 2002 and 2004)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Performance of different mono- and multiplex nucleic acid amplification tests on a multipathogen external quality assessment panel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Promising new assays and technologies for the diagnosis and management of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Usage of veterinary therapeutic antimicrobials in Denmark, Norway and Sweden following termination of antimicrobial growth promoter use.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Food animals and antimicrobials: impacts on human health

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Selective pressure by antibiotic use in livestock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Changes in the use of antimicrobials and the effects on productivity of swine farms in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2011

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Drug-resistant Salmonella from animals fed antimicrobials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The attribution of human infections with antimicrobial resistant Salmonella bacteria in Denmark to sources of animal origin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Fate and transport of antibiotic residues and antibiotic resistance genes following land application of manure waste

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Characterization of plasmid-mediated AmpC-producing E. coli from Swedish broilers and association with human clinical isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Human Health Risk Assessment (HHRA) for environmental development and transfer of antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial stewardship: Time for change

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Meeting the challenge of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Access to medicines from a health system perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Towards new business models for R&D for novel antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

3Rs for innovating novel antibiotics: sharing resources, risks, and rewards

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Silver enhances antibiotic activity against gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Combination therapies for combating antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Combination drugs, an emerging option for antibacterial therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Vaccines and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Rapid molecular detection of tuberculosis and rifampin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Availability of antibiotics for purchase without a prescription on the internet

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Treatment of otitis media with observation and a safety-net antibiotic prescription

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Improving inpatient antibiotic prescribing: insights from participation in a national collaborative

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotic use among patients with febrile illness in a low malaria endemicity setting in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Community acceptability and adoption of integrated community case management in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: a multi-country cluster randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Quality and safety of integrated community case management of malaria using rapid diagnostic tests and pneumonia by community health workers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Economic evaluation of Mectizan distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotics as part of the management of severe acute malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial stewardship: a matter of process or outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A framework for collaborative improvement: lessons from the Institute for Healthcare Improvement's Breakthrough Series

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial resistance in developing countries. Part II: strategies for containment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotic sensitivity pattern of causative organisms of neonatal septicemia in an urban hospital of Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Neonatal bloodstream infections in a pediatric hospital in Vietnam: a cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Pathogens associated with sepsis in newborns and young infants in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Sensitivity pattern among bacterial isolates in neonatal septicaemia in port Harcourt

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Susceptibility of community-acquired pathogens to antibiotics in Africa and Asia in neonates--an alarmingly short review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Streptococcus pneumoniae: does antimicrobial resistance matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial resistance of respiratory pathogens in North African countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

[Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000-2005].

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Virulence and multidrug resistance patterns of Vibrio cholerae O1 isolates from diarrheal outbreaks of South India during 2006-2009.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Prevalence and antibiotic resistance of bacterial pathogens isolated from childhood diarrhoea in four provinces of Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Molecular characterisation of Vibrio cholerae O1 strains carrying an SXT/R391-like element from cholera outbreaks in Kenya: 1994-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Cholera in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Emergence of classical ctxB genotype 1 and tetracycline resistant strains of Vibrio cholerae O1 El Tor in Assam, India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Tropical bacterial gastrointestinal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Genetic characteristics and changing antimicrobial resistance among Shigella spp. isolated from hospitalized diarrhoeal patients in Kolkata, India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Bacterial aetiology of diarrhoeal diseases and antimicrobial resistance in Dhaka, Bangladesh, 2005-2008.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial resistance in developing countries. Part I: recent trends and current status

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Nontherapeutic use of antimicrobial agents in animal agriculture: implications for pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Population-based surveillance of typhoid fever in Egypt.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Salmonella typhi in the democratic republic of the congo: fluoroquinolone decreased susceptibility on the rise

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Salmonella meningitis in children in Blantyre, Malawi, 1996-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006-2009

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Molecular epidemiology of community-acquired invasive non-typhoidal Salmonella among children aged 2 29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial resistance in invasive non-typhoid Salmonella from the Democratic Republic of the Congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from India.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A view on antimicrobial resistance in developing countries and responsible risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics--systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Food and agriculture policy: issues related to prevention of noncommunicable diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The Chennai declaration on antimicrobial resistance in India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The WHO policy package to combat antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Role of the private sector in the provision of immunization services in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Novel classes of antibiotics or more of the same?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial drug development--the past, the present, and the future

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

1 reference

7 January 2021

The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotics in phase II and III clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Introduction to antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Near absence of methicillin-resistance and pronounced genetic diversity among Staphylococcus epidermidis isolated from healthy persons in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Drug discovery: new models for industry-academic partnerships

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

New NIH center broadens scope of translational research

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Infectious disease. Approval of novel TB drug celebrated--with restraint

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Fix the antibiotics pipeline.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Fighting bacterial infections-future treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Drugs for bad bugs: confronting the challenges of antibacterial discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Bioactive microbial metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Thoughts and facts about antibiotics: where we are now and where we are heading

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Is the GAIN Act a turning point in new antibiotic discovery?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibiotic adjuvants: multicomponent anti-infective strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Three decades of beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

New β-lactam-β-lactamase inhibitor combinations in clinical development

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A small molecule discrimination map of the antibiotic resistance kinome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Palmitoyl-DL-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antivirulence as a new antibacterial approach for chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Small molecules that modulate quorum sensing and control virulence in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Inhibition of virulence gene expression in Staphylococcus aureus by novel depsipeptides from a marine photobacterium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Method for screening compounds that influence virulence gene expression in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Chemical inhibitors of the type three secretion system: disarming bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Newly Discovered and Characterized Antivirulence Compounds Inhibit Bacterial Mono-ADP-Ribosyltransferase Toxins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

An in vitro screen of bacterial lipopolysaccharide biosynthetic enzymes identifies an inhibitor of ADP-heptose biosynthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Marketed therapeutic antibodies compendium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Anti-bacterial monoclonal antibodies: back to the future?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antibodies for the treatment of bacterial infections: current experience and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Modulating immunity as a therapy for bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Potential of immunomodulatory host defense peptides as novel anti-infectives

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Vaccine development: Man vs MRSA

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

A framework for global surveillance of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970318-9

7 January 2021

10.1016/S1473-3099(13)70318-9

Identifiers

DOI

1 reference

1 August 2017

1 reference